Raymond James Financial Services Advisors, Inc. Lexaria Bioscience Corp. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 44,900 shares of LEXX stock, worth $110,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,900
Previous 48,800
7.99%
Holding current value
$110,005
Previous $135,000
0.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LEXX
# of Institutions
28Shares Held
2.05MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$2.5 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.26 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$281,2180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA93.6KShares$229,2850.0% of portfolio
-
Gen Trust, LLC60KShares$147,0000.01% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $14.6M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...